Little is known about how DCs are recruited to the TME in colon cancer, but a study in a mouse model of colon cancer showed that tumor-residing NK cells produce the chemokines XCL1 and CCL5 which attract cDC1 into the tumor where NK cells and other cells enhance their activation for efficient anti-tumor responses (192). This evidence concerns the gene CCL5 and colonic neoplasm.